Clinical Trial Update: A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population [Phase 3]

View source ↗

Summary

A Phase 3 trial update notes ongoing recruitment for Barhemsys (rolapitant) to prevent postoperative nausea and vomiting in adults undergoing bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Barhemsys (rolapitant)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Post Operative Nausea and Vomiting | Phase 3 | Status: RECRUITING